Chipotle 2008 Annual Report Download - page 71

Download and view the complete annual report

Please find page 71 of the 2008 Chipotle annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 110

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110

Class II directors whose terms expire at the 2010
annual meeting of shareholders Age
Director
Since
Albert S. Baldocchi ....................... Mr.Baldocchi has been self-employed since
2000 as a financial consultant and strategic
advisor for a variety of privately-held
companies with a specialization in multi-unit
restaurant companies. Mr. Baldocchi holds a
Bachelor of Science degree in chemical
engineering from the University of California
at Berkeley and an MBA from Stanford
University.
55 1997
Neil W. Flanzraich ........................ Mr.Flanzraich has been a private investor
since February 2006. From 1998 through its
sale in January 2006 to TEVA
Pharmaceuticals Industries, Ltd., he served as
Vice Chairman and President of IVAX
Corporation, an international pharmaceutical
company. From 1995 to 1998, Mr. Flanzraich
served as Chairman of the Life Sciences Legal
Practice Group of Heller Ehrman LLP, a law
firm, and from 1991 to 1995, Mr. Flanzraich
served as Senior Vice President and a member
of the Corporate Operating Committee of
Syntex Corporation, an international
pharmaceutical company. He is also a director
of Continucare Corporation (Amex:CNU),
Equity One Inc. (NYSE:EQY), Javelin
Pharmaceuticals, Inc. (Amex:JAV), BELLUS
Health Inc. (TSX:BLUS), and RAE Systems,
Inc. (Amex:RAE). Mr. Flanzraich received an
A.B. from Harvard College (phi beta kappa,
magna cum laude) and a J.D. from Harvard
Law School (magna cum laude).
65 2007
Darlene J. Friedman ....................... Prior to retiring in 1995, Ms. Friedman spent
19 years at Syntex Corporation where she
held a variety of management positions, most
recently as Senior Vice President of Human
Resources. While at Syntex Corporation,
Ms. Friedman was a member of the corporate
executive committee and the management
committee. Ms. Friedman holds a Bachelor of
Arts degree in psychology from the
University of California at Berkeley and an
MBA from the University of Colorado.
66 1995
8
Proxy Statement